Company Name or Ticker Symbol
Search for other Categories
Enzo Biochem Inc  (ENZ)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories


Loss Despite Sales Growth

decrease font size NEWS BETA Increase font size

Enzo Biochem Inc announced second quarter 2016 operating loss of $-1.009 millions

Enzo Biochem Inc announced earnings per share of $-0.02 and Sales of $26 millions in the second quarter 2016, Company's losses widen per share, versus $0.15 eps, earned in the same quarter a year ago, although Enzo Biochem Inc saw it's Sales rise by 6.92 % in the same period.

Sales decreased by -0.09 % from $26 millions in preceding period, improved from $-0.03 per share.

For the second quarter 2016 Enzo Biochem Inc logged net loss of $-1 million, instead of net income of $7 millions achieved in the same quarter a year before.
Other ENZ's Earnings Reports

Enzo Biochem Inc reported first quarter 2016 earnings

Enzo Biochem Inc reported forth quarter 2016 earnings

Enzo Biochem Inc reported third quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com